ClinicalTrials.gg
WithdrawnNCT04491903Updated May 4, 2021

REBOA for Out-of-hospital Cardiac Arrest

An interventional study of REBOA in Cardiac Arrest, sponsored by neurescue. Withdrawn. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2021-05-04.

Sponsored by neurescue · Not applicable, Interventional, and Treatment

How we know

Why this study was withdrawn
Withdrawn

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Cardiac arrest is a major health problem that carries a high mortality rate. Substantial research and development have been put into changing the outcome of cardiac arrest and despite the advent of automated external defibrillators (AED), increase in bystander Cardiopulmonary resuscitation (CPR) and automated CPR devices (ACPR), the proportion of patient survival to hospital discharge has only minimally improved.

The objective is to investigate safety and performance of the Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) procedure as an adjunct to Advanced Life Support (ALS) for treatment of refractory cardiac arrest.

Read the detailed description

The scope of the study is to collect data on patients with refractory out of hospital cardiac arrest (OHCA) for this feasibility study.

Data collected:

  • from enrolment of the patient until hospital arrival
  • every 24 hours
  • at discharge or 7 days post enrollment
  • at 30 days post enrollment

The investigation is initiated to investigate the safety and performance of the REBOA procedure for patients experiencing refractory OHCA.

02

Conditions studied

  • Cardiac Arrest

Browse trials for

03

In context

Heart Arrest

927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.

Browse Heart Arrest studies →

Lead sponsor

neurescue is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Witnessed cardiac arrest
  • Bystander or professional CPR within 5 minutes
  • cardiac arrest

Exclusion criteria

Exclusion Criteria:

  • End Tidal CO2 \<1,3 kPa
  • Traumatic cardiac arrest
  • Women with known pregnancy
  • Patients with known terminal disease
  • Patients with known do-not-attempt-CPR order
  • Patients with overdose
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Relapsed and refractory

Relapsed: the illness came back after treatment had worked. Refractory: it did not respond to treatment, or stopped responding while still on it.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    REBOA

    Procedure: REBOA

Interventions

  • ProcedureREBOA

    Endovascular balloon occlusion of the aorta

06

What researchers measure

Primary outcomes

  1. Central blood pressure

    Time frame: 1 hour

Secondary outcomes

  1. Return of spontaneous circulation (ROSC)

    Time frame: 1 hour

  2. Changes in cardiac rhythm following balloon inflation

    Time frame: 1 hour

  3. During procedure - time from first needle stick to successful sheath insertion

    Time frame: 1 hour

  4. During procedure - time from first needle stick to finalized balloon inflation

    Time frame: 1 hour

  5. End-tidal CO2 (EtCO2)

    Time frame: 1 hour

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Individual request

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2020; primary completion for Nov 2020, 0 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 22, 2020
First posted
Jul 30, 2020
StartEst.
Nov 30, 2020
Primary completionEst.
Nov 30, 2020
CompletionEst.
Nov 30, 2020
Last update
May 4, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 4, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04491903
Lead sponsor
neurescue
Responsible party
Sponsor
First posted
Jul 30, 2020
Start date
Nov 30, 2020 (estimated)
Primary completion
Nov 30, 2020 (estimated)
Completion
Nov 30, 2020 (estimated)
Last update
May 4, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion